6 research outputs found
Hormonal control during infancy and testicular adrenal rest tumor development in males with congenital adrenal hyperplasia: a retrospective multicenter cohort study
IMPORTANCE
Testicular adrenal rest tumors (TARTs), often found in male patients with congenital adrenal hyperplasia (CAH), are benign lesions causing testicular damage and infertility. We hypothesize that chronically elevated adrenocorticotropic hormone exposure during early life may promote TART development.
OBJECTIVE
This study aimed to examine the association between commencing adequate glucocorticoid treatment early after birth and TART development.
DESIGN AND PARTICIPANTS
This retrospective multicenter (n = 22) open cohort study collected longitudinal clinical and biochemical data of the first 4 years of life using the I-CAH registry and included 188 male patients (median age 13 years; interquartile range: 10-17) with 21-hydroxylase deficiency (n = 181) or 11-hydroxylase deficiency (n = 7). All patients underwent at least 1 testicular ultrasound.
RESULTS
TART was detected in 72 (38%) of the patients. Prevalence varied between centers. When adjusted for CAH phenotype, a delayed CAH diagnosis of >1 year, compared with a diagnosis within 1 month of life, was associated with a 2.6 times higher risk of TART diagnosis. TART onset was not predicted by biochemical disease control or bone age advancement in the first 4 years of life, but increased height standard deviation scores at the end of the 4-year study period were associated with a 27% higher risk of TART diagnosis.
CONCLUSIONS AND RELEVANCE
A delayed CAH diagnosis of >1 year vs CAH diagnosis within 1 month after birth was associated with a higher risk of TART development, which may be attributed to poor disease control in early life
Transcriptional comparison of Testicular Adrenal Rest Tumors with fetal and adult tissues
BACKGROUND: Testicular Adrenal Rest Tumors (TART) are a common complication of unknown cellular origin in patients with Congenital Adrenal Hyperplasia (CAH). These benign tumors have both adrenal and testicular characteristics and are hypothesized to either derive from cells of adrenal origin from the fetal adrenogonadal primordium or by atypical differentiation of adult Leydig-progenitor cells. OBJECTIVE: This study aims to unravel the identity and etiology of TART. METHODS: Co-expression of adrenal-specific CYP11B1 and Leydig cell-specific HSD17B3 in TART was studied using immunohistochemistry. We studied the possibility of TART being derived from atypical differentiation of adult Leydig-progenitor cells by the quantification of adrenal-specific enzyme expression upon ACTH-like stimulation of ex vivo cultured PDGFRA-positive cells. By comparing the transcriptome of TART (n=16) with the transcriptome of fetal adrenal (n=13), fetal testis (n=5), adult adrenal (n=11) and adult testis (n=10) tissues, we explored the identity of TART. RESULTS: We demonstrate co-expression of adrenal-specific CYP11B1 and testis-specific HSD17B3 in TART cells, indicating the existence of a distinct TART cell exhibiting both adrenal and testicular characteristics. Ex vivo cultured adult Leydig-progenitor cells did not express the ACTH-receptor MC2R but did express CYP11B1 upon stimulation. Unsupervised clustering of transcriptome data showed that TART was most similar to adult adrenal tissue, followed by adult testis tissue, and least similar to either fetal tissue. CONCLUSION: Our data suggest that TART is induced -most likely via activation of a cAMP/PKA dependent receptor-from a progenitor cell into a unique mature adrenal-like cell type, sometimes exhibiting both adrenal and testicular features